RHOA and cutaneous melanoma: For example, >80% of uveal melanomas and ~6% of cutaneous melanomas have mutations in GNAQ/GNA1 proteins, which stimulate RhoA activity and activate YAP/TAZ independent of any alterations in LATS1/272–74.